Comprehensive mapping of genetic variation at Epromoters reveals pleiotropic association with multiple disease traits
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkae1270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Jing Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Aix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France. Hauptthemen laut MEDLINE: Promoter Regions, Genetic, Enhancer Elements, Genetic, Genetic Pleiotropy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale, Aix-Marseille University, Agence Nationale pour la Recherche.
Abstract (Originalsprache)
There is growing evidence that a wide range of human diseases and physiological traits are influenced by genetic variation of cis-regulatory elements. We and others have shown that a subset of promoter elements, termed Epromoters, also function as enhancer regulators of distal genes. This opens a paradigm in the study of regulatory variants, as single nucleotide polymorphisms (SNPs) within Epromoters might influence the expression of several (distal) genes at the same time, which could disentangle the identification of disease-associated genes. Here, we built a comprehensive resource of human Epromoters using newly generated and publicly available high-throughput reporter assays. We showed that Epromoters display intrinsic and epigenetic features that distinguish them from typical promoters. By integrating Genome-Wide Association Studies (GWAS), expression Quantitative Trait Loci (eQTLs) and 3D chromatin interactions, we found that regulatory variants at Epromoters are concurrently associated with more disease and physiological traits, as compared with typical promoters. To dissect the regulatory impact of Epromoter variants, we evaluated their impact on regulatory activity by analyzing allelic-specific high-throughput reporter assays and provided reliable examples of pleiotropic Epromoters. In summary, our study represents a comprehensive resource of regulatory variants supporting the pleiotropic role of Epromoters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aix-Marseille University, INSERM, TAGC, UMR 1090 Marseille, France.
- Equipe Labellisée LIGUE, 2023 Marseille, France.
- Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, UMR 5535, Montpellier, France.
ORCID-Profile: Benoit Ballester, Salvatore Spicuglia
Förderung
- Institut National de la Santé et de la Recherche Médicale
- Aix-Marseille University
- Agence Nationale pour la Recherche
- Ligue Contre le Cancer
- Innovative Training Network 'Molecular Basis of Human Enhanceropathies'
- Marseille Institute of Rare Diseases
- FRM
- MSCA
Zitieren
APA
Wan, J., van Ouwerkerk, A., Mouren, J. C., Heredia, C., Pradel, L., Ballester, B., Andrau, J. C., & Spicuglia, S. (2025). Comprehensive mapping of genetic variation at Epromoters reveals pleiotropic association with multiple disease traits. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae1270
Vancouver
Wan J, van Ouwerkerk A, Mouren JC, Heredia C, Pradel L, Ballester B, et al. Comprehensive mapping of genetic variation at Epromoters reveals pleiotropic association with multiple disease traits. Nucleic Acids Research. 2025. doi:10.1093/nar/gkae1270
BibTeX
@article{Wan2025,
author = {Wan, Jing and van Ouwerkerk, Antoinette and Mouren, Jean-Christophe and Heredia, Carla and Pradel, Lydie and Ballester, Benoit and Andrau, Jean-Christophe and Spicuglia, Salvatore},
title = {Comprehensive mapping of genetic variation at Epromoters reveals pleiotropic association with multiple disease traits},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkae1270}
}
EUVIMED